Contribution of Apolipoprotein L1 () Risk Alleles to Kidney Disease in West Africa: an opportunity for treatment.
作者信息
Adu Dwomoa
机构信息
University of Ghana Medical School Accra, Ghana.
出版信息
Ghana Med J. 2024 Dec;58(4):249-250. doi: 10.4314/gmj.v58i4.1.
Abstract
摘要
相似文献
1
Contribution of Apolipoprotein L1 () Risk Alleles to Kidney Disease in West Africa: an opportunity for treatment.
Ghana Med J. 2024 Dec;58(4):249-250. doi: 10.4314/gmj.v58i4.1.
2
Apolipoprotein L1 gene variants and kidney disease in patients with HIV: a systematic review and meta-analysis.
J Nephrol. 2023 May;36(4):1119-1134. doi: 10.1007/s40620-022-01512-9. Epub 2022 Dec 13.
3
Sickle cell trait, APOL1 risk allele status and chronic kidney disease among ART-experienced adults living with HIV in northern Nigeria.
Int J STD AIDS. 2025 Jul;36(8):655-663. doi: 10.1177/09564624241262397. Epub 2024 Jun 24.
4
Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
Clin J Am Soc Nephrol. 2022 Jun;17(6):798-808. doi: 10.2215/CJN.14321121. Epub 2022 May 16.
5
Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression.
Clin J Am Soc Nephrol. 2022 Oct;17(10):1477-1486. doi: 10.2215/CJN.02680322. Epub 2022 Aug 31.
6
APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int. 2025 Jun 23. doi: 10.1016/j.kint.2025.05.017.
7
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury.
Cells. 2025 Jul 2;14(13):1011. doi: 10.3390/cells14131011.
8
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice.
bioRxiv. 2024 Dec 28:2024.12.28.630625. doi: 10.1101/2024.12.28.630625.
9
Association Between Genotypes and Risk of Cardiovascular Disease in MESA (Multi-Ethnic Study of Atherosclerosis).
J Am Heart Assoc. 2017 Dec 21;6(12):e007199. doi: 10.1161/JAHA.117.007199.
10
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice.
Clin Sci (Lond). 2025 May 27. doi: 10.1042/CS20255324.
本文引用的文献
1
Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.
N Engl J Med. 2025 Jan 16;392(3):228-238. doi: 10.1056/NEJMoa2404211. Epub 2024 Oct 26.
2
Inaxaplin for Proteinuric Kidney Disease in Persons with Two Variants.
N Engl J Med. 2023 Mar 16;388(11):969-979. doi: 10.1056/NEJMoa2202396.
3
Overview of The Human Heredity and Health in Africa Kidney Disease Research Network (H3A-KDRN).
Kidney360. 2020 Dec 8;2(1):129-133. doi: 10.34067/KID.0002592020. eCollection 2021 Jan 28.
4
Chronic kidney disease burden among African migrants in three European countries and in urban and rural Ghana: the RODAM cross-sectional study.
Nephrol Dial Transplant. 2018 Oct 1;33(10):1812-1822. doi: 10.1093/ndt/gfx347.
5
The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.
Lancet Glob Health. 2014 Mar;2(3):e174-81. doi: 10.1016/S2214-109X(14)70002-6. Epub 2014 Feb 10.
6
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Science. 2010 Aug 13;329(5993):841-5. doi: 10.1126/science.1193032. Epub 2010 Jul 15.
7
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Hum Genet. 2010 Sep;128(3):345-50. doi: 10.1007/s00439-010-0861-0. Epub 2010 Jul 16.
8
The trypanolytic factor of human serum.
Nat Rev Microbiol. 2006 Jun;4(6):477-86. doi: 10.1038/nrmicro1428.
Zotero 插件